|
DIP2C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.56534999999902E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.810480E-04 |
| Normal-vs-Stage2 |
6.807400E-04 |
| Normal-vs-Stage3 |
2.476200E-03 |
| Normal-vs-Stage4 |
2.30820000000076E-05 |
| Stage1-vs-Stage2 |
7.059600E-01 |
| Stage1-vs-Stage3 |
6.063000E-01 |
| Stage1-vs-Stage4 |
3.762300E-02 |
| Stage2-vs-Stage3 |
8.449000E-01 |
| Stage2-vs-Stage4 |
1.317170E-01 |
| Stage3-vs-Stage4 |
2.760600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.12830000000586E-05 |
| Normal-vs-AfricanAmerican |
1.604260E-04 |
| Normal-vs-Asian |
1.553760E-02 |
| Caucasian-vs-AfricanAmerican |
6.097000E-01 |
| Caucasian-vs-Asian |
4.293000E-01 |
| AfricanAmerican-vs-Asian |
3.582800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.58907999999736E-05 |
| Normal-vs-Female |
5.215400E-04 |
| Male-vs-Female |
4.951800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.40880000000177E-05 |
| Normal-vs-Extreme_Weight |
1.87801999999015E-05 |
| Normal-vs-Obese |
2.409900E-02 |
| Normal-vs-Extreme_Obese |
2.518200E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.741200E-01 |
| Normal_Weight-vs-Obese |
1.016960E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.717400E-01 |
| Extreme_Weight-vs-Obese |
4.412500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.765600E-01 |
| Obese-vs-Extreme_Obese |
6.578600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.243660E-02 |
| Normal-vs-Age(41-60Yrs) |
2.421300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.9032599999913E-05 |
| Normal-vs-Age(81-100Yrs) |
9.75290000000406E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.317600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.907400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.330000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.221030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.705030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.542400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.591400E-04 |
| Normal-VS-Type2 PRCC |
6.28929999999528E-05 |
| Normal-VS-KIRP CIMP |
3.74980000050762E-07 |
| Normal-VS-Unclassified PRCC |
4.382000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.234200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.162040E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.347800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.662800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.552200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.400260E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.177100E-04 |
| Normal-vs-N1 |
1.88410000001582E-06 |
| Normal-vs-N2 |
2.921700E-02 |
| N0-vs-N1 |
4.083800E-02 |
| N0-vs-N2 |
3.434200E-01 |
| N1-vs-N2 |
8.038800E-01 |
|
|
